NVTA stock forecast
Our latest prediction for Invitae Corp.'s stock price was made on the Aug. 19, 2019 when the stock price was at 25.77$.
In the short term (2weeks), NVTA's stock price should outperform the market by 1.30%. During that period the price should oscillate between -6.97% and +8.04%.
In the medium term (3months), NVTA's stock price should outperform the market by 3.55%. During that period the price should oscillate between -16.30% and +23.36%.Get email alerts
About Invitae Corp.
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.
At the moment the company generates 196M USD in revenues.
On its last earning announcement, the company reported a loss of -2.24$ per share.
The book value per share is 2.00$
Three months stock forecastAug. 19, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|